Page last updated: 2024-09-02

asulacrine and Neoplasms

asulacrine has been researched along with Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afzal, A; Sarfraz, M; Sun, J; Wang, G; Wu, Z1
Baguley, BC; Carmichael, J; Fyfe, D; Gardner, C; Houghton, J; Langley, RE; Osborne, L; Pagonis, C; Price, C; Woll, PJ1
Benson, L; Doroshow, JH; Grove, WR; Maroun, JA; Mittelman, A; Robert, F; Rosen, PJ; Sklarin, NT; Stewart, JA; Wiernik, PH1
Baguley, BC; Evans, P; Grillo-Lopez, AJ; Grove, W; Hardy, JR; Harvey, VJ; Paxton, JW; Smith, S1

Reviews

1 review(s) available for asulacrine and Neoplasms

ArticleYear
Integrated scientific data bases review on asulacrine and associated toxicity.
    Critical reviews in oncology/hematology, 2016, Volume: 104

    Topics: Amsacrine; Animals; Antineoplastic Agents; Humans; Neoplasms; Oxidative Stress; Signal Transduction

2016

Trials

2 trial(s) available for asulacrine and Neoplasms

ArticleYear
A phase I trial of amsalog (CI-921) administered by intravenous infusion using a 5-day schedule.
    Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:4

    Topics: Adult; Aged; Amsacrine; Antineoplastic Agents; Area Under Curve; Bone Marrow Diseases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Topoisomerase II Inhibitors

2001
A phase II trial of CI-921 in advanced malignancies.
    Investigational new drugs, 1992, Volume: 10, Issue:4

    Topics: Adult; Aged; Amsacrine; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neoplasms; Treatment Outcome

1992

Other Studies

1 other study(ies) available for asulacrine and Neoplasms

ArticleYear
Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921).
    Cancer research, 1988, Nov-15, Volume: 48, Issue:22

    Topics: Adult; Aged; Amsacrine; Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms

1988